Q3 2023 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2023-11-13 · accession 0001104659-23-117294
$62.7M
Reported value
7
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 433000106 | HIMS | Hims & Hers Health, Inc. | $23.5M | 37.5% | 3,733,381 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $11.4M | 18.3% | 243,513 | Common | SOLE |
| 88369M101 | — | Theseus Pharmaceuticals, Inc. | $11.1M | 17.6% | 4,108,796 | Common | SOLE |
| 00461U105 | ACRS | Aclaris Therapeutics, Inc. | $8.6M | 13.8% | 1,258,243 | Common | SOLE |
| 49705R105 | KNTEUSD | Kinnate Biopharma Inc. | $4.9M | 7.88% | 3,525,957 | Common | SOLE |
| 20454B104 | CMPX | Compass Therapeutics, Inc. | $2.5M | 3.92% | 1,246,977 | Common | SOLE |
| N69605108 | PHVS | Pharvaris N.V. | $691,674 | 1.10% | 33,142 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.